260,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Broschiertes Buch

Octacalcium Phosphate Biomaterials: Past, Present and Future is a comprehensive study of octacalcium phosphate (OCP), a next generation biomaterial for bone regeneration. By focusing both on fundamental research and the use of OCP as a scaffold material, this book explores its potential to deliver improved clinical results. Early chapters in the book discuss OCP's effects on bone cell activity, cellular interactions and their role in bone formation, repair and replacement. Later chapters cover topics such as drug delivery, synthesis methodologies and future analysis techniques. This will be an…mehr

Produktbeschreibung
Octacalcium Phosphate Biomaterials: Past, Present and Future is a comprehensive study of octacalcium phosphate (OCP), a next generation biomaterial for bone regeneration. By focusing both on fundamental research and the use of OCP as a scaffold material, this book explores its potential to deliver improved clinical results. Early chapters in the book discuss OCP's effects on bone cell activity, cellular interactions and their role in bone formation, repair and replacement. Later chapters cover topics such as drug delivery, synthesis methodologies and future analysis techniques. This will be an invaluable and unique resource for researchers, clinicians, students and industrialists in the area of orthopedics and dentistry.

OCP is known to be a pre-cursor to hydroxyapatite in the human biomineralization process that forms bone and tooth enamel. Research studies that have emerged in recent years suggest OCP's tremendous potential as a bioactive material.

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Gerard Insley is Chief Scientific Officer at CelgenTek and ZimmerBiomet.
Gerard is a scientist and inventor based in Ireland. Gerard has worked in the life science arena for over twenty five years focussing on biomaterials for skeletal repair. Gerard's main passion is inspiring technical teams to solve the many difficulties facing clinicians in repairing replacing and augmenting fractured and compromised bone.
With over a dozen biomaterials products commercialised and currently on the market, Gerard continues to focus on developing disruptive biomaterials based solutions for unsolved clinical problems. These include the first load bearing biomaterial for hip revision applications BoneSaveT, first Calcium Phosphate cement for screw augmentation trauma applications HydrosetT and the first premixed calcium cement on the market iN3T.
Gerard has worked with Howmedica Stryker and Zimmer and has co-founded 4 biomaterials companies with over 30 peer reviewed publications presenta

tions and posters and more than a dozen patents in the field.